Competition law and pricing among biologic drugs: the case of VEGF therapy for retinal diseases
{{output}}
Neovascular age-related macular degeneration (AMD) is a progressive eye disease and is a leading cause of vision loss in the Western world. Vascular endothelial growth factor inhibitors have become a mainstay of treatment for this disease. Currently, treatment... ...
